|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-2-10
|
|
pubmed:abstractText |
Heparin bonding of the cardiopulmonary bypass (CPB) circuit may be associated with a reduced inflammatory response and improved clinical outcome. The relative contribution of a heparin-bonded oxygenator (ie, >80% of circuit surface area) to these effects was assessed in a group of pediatric patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1790-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9436574-Cardiopulmonary Bypass,
pubmed-meshheading:9436574-Child, Preschool,
pubmed-meshheading:9436574-Complement Membrane Attack Complex,
pubmed-meshheading:9436574-Heparin,
pubmed-meshheading:9436574-Humans,
pubmed-meshheading:9436574-Infant,
pubmed-meshheading:9436574-Infant, Newborn,
pubmed-meshheading:9436574-Interleukin-6,
pubmed-meshheading:9436574-Interleukin-8,
pubmed-meshheading:9436574-Leukocyte Count,
pubmed-meshheading:9436574-Leukocyte Elastase,
pubmed-meshheading:9436574-Oxygenators,
pubmed-meshheading:9436574-Prospective Studies,
pubmed-meshheading:9436574-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
|
|
pubmed:affiliation |
Cardiothoracic Surgery Department, Killingbeck Hospital, Leeds, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
